EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--May 11, 2006--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT - News), a specialty pharmaceutical company focused on developing, manufacturing and marketing novel therapeutic products for unmet medical needs, announced today results for the first quarter ended March 31, 2006.
